Literature DB >> 15016360

Peptide sequence and amyloid formation; molecular simulations and experimental study of a human islet amyloid polypeptide fragment and its analogs.

David Zanuy1, Yair Porat, Ehud Gazit, Ruth Nussinov.   

Abstract

We present a combined experimental and theoretical investigation of the tendencies to form amyloid fibrils by a hexapeptide derivative of the human islet amyloid polypeptide, the NFGAIL (22-27) fragment and its mutants. We performed a complete alanine scan of this fragment and studied the capability of the wild-type and its mutant analogs to form ordered fibrils by ultrastructural and biophysical analyses. In parallel, we conducted a meticulous characterization of each sequence-complex at an atomistic level by performing nine independent molecular dynamics simulations for a total of 36 ns. These allowed us to rationalize the experimental observations and to establish the role of every residue in the fibrillogenesis. The main factor that determines the formation of regular fibrils is a coherent organization of the intersheet space. In particular, phenylalanine side chains cement the macromolecular assemblies due to their aromatic chemical character and restricted conformational flexibility when interacting with aliphatic residues.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016360     DOI: 10.1016/j.str.2004.02.002

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  18 in total

1.  Molecular basis for amyloid fibril formation and stability.

Authors:  O Sumner Makin; Edward Atkins; Pawel Sikorski; Jan Johansson; Louise C Serpell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-03       Impact factor: 11.205

2.  Structural stability and dynamics of an amyloid-forming peptide GNNQQNY from the yeast prion sup-35.

Authors:  Jie Zheng; Buyong Ma; Chung-Jung Tsai; Ruth Nussinov
Journal:  Biophys J       Date:  2006-05-05       Impact factor: 4.033

3.  Assessing the role of aromatic residues in the amyloid aggregation of human muscle acylphosphatase.

Authors:  Francesco Bemporad; Niccolò Taddei; Massimo Stefani; Fabrizio Chiti
Journal:  Protein Sci       Date:  2006-04       Impact factor: 6.725

4.  Changing the charge distribution of beta-helical-based nanostructures can provide the conditions for charge transfer.

Authors:  Nurit Haspel; David Zanuy; Jie Zheng; Carlos Aleman; Haim Wolfson; Ruth Nussinov
Journal:  Biophys J       Date:  2007-04-06       Impact factor: 4.033

5.  Investigating the mechanism of peptide aggregation: insights from mixed monte carlo-molecular dynamics simulations.

Authors:  Massimiliano Meli; Giulia Morra; Giorgio Colombo
Journal:  Biophys J       Date:  2008-02-08       Impact factor: 4.033

6.  Structural properties of Abeta protofibrils stabilized by a small molecule.

Authors:  Angela D Williams; Matt Sega; Maolian Chen; Indu Kheterpal; Merav Geva; Valerie Berthelier; David T Kaleta; Kelsey D Cook; Ronald Wetzel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

7.  Unique example of amyloid aggregates stabilized by main chain H-bond instead of the steric zipper: molecular dynamics study of the amyloidogenic segment of amylin wild-type and mutants.

Authors:  Workalemahu Mikre Berhanu; Artëm E Masunov
Journal:  J Mol Model       Date:  2011-05-28       Impact factor: 1.810

8.  Stability and structure of oligomers of the Alzheimer peptide Abeta16-22: from the dimer to the 32-mer.

Authors:  Ute F Röhrig; Alessandro Laio; Nazario Tantalo; Michele Parrinello; Roberto Petronzio
Journal:  Biophys J       Date:  2006-08-18       Impact factor: 4.033

Review 9.  Folding versus aggregation: polypeptide conformations on competing pathways.

Authors:  Thomas R Jahn; Sheena E Radford
Journal:  Arch Biochem Biophys       Date:  2007-06-08       Impact factor: 4.013

10.  Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitor.

Authors:  Roni Scherzer-Attali; Riccardo Pellarin; Marino Convertino; Anat Frydman-Marom; Nirit Egoz-Matia; Sivan Peled; Michal Levy-Sakin; Deborah E Shalev; Amedeo Caflisch; Ehud Gazit; Daniel Segal
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.